Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2023-11-01 Interim / Quarterly Rep…
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q3 2023
2023-11-01 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 1, 2023, reporting the results of operations for the three and nine months ended September 30, 2023. It includes a press release as an exhibit announcing these results. The text explicitly states that the information is being furnished and not filed, and it references a press release rather than containing detailed financial statements or analysis itself. The document length is 3486 characters, which is relatively short and consistent with a regulatory announcement rather than a full interim or quarterly report. According to the rules, such a document announcing results via a press release and not containing substantive financial data should be classified as a Regulatory Filing (RNS), not as an Interim Report (IR) or Earnings Release (ER).
2023-11-01 English
FORM 4
Director's Dealing
2023-10-31 English
FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the completion of an acquisition or disposition of assets, specifically the sale of the Respiratory Health business assets. It references the Purchase Agreement and its amendment, and includes exhibits related to these agreements. The document is not a full financial report but an announcement of a significant transaction event. This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including asset sales. The document length is about 5,078 characters, which is consistent with a detailed 8-K filing. Therefore, the appropriate classification is TAR with high confidence.
2023-10-02 English
FORM 10-Q
Interim / Quarterly Report Q2 2023
2023-08-09 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 9, 2023, which is a current report used to announce unscheduled material events or corporate changes. The content discusses a Regulation FD Disclosure clarifying market misinformation about the company's Q2 2023 earnings results, referencing an earnings release previously filed. It does not contain the earnings release itself or detailed financial statements but rather commentary and clarification on reported financial results. The document length is 4420 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. The document also includes a signature block and an exhibit reference to the cover page interactive data file, typical for an 8-K filing. Given these factors, the document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories like Earnings Release or Interim Report.
2023-08-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.